DALLAS, June 27, 2011 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces a stock report featuring Lannett Company Inc. (AMEX:LCI). The report briefly notes the company's most recent developments and news, and outlines its financial position, market performance, and comparison against industry peers.
The full report is available at: www.microstockprofit.com/lp/LCI
Lannett Company Inc. (LCI) engages in the development, manufacture and distribution of generic prescription pharmaceutical products in tablet, capsule and oral liquid forms to customers throughout the United States. It also produces a limited number of private label pharmaceutical products for other companies. Additionally, LCI, through its wholly owned subsidiary, manufactures active pharmaceutical ingredients (APIs). The Company markets its products primarily to drug wholesalers, retail drug chains, distributors and government agencies.
This newsletter has been helping traders make great investment decisions on LCI; click here for a 25% discount offer.
In the report, the analyst notes:
"Shares in LCI sank by more than 11% on Friday despite the generic drug maker reporting an FDA approval for its new drug application (NDA) for morphine sulfate oral solution. Shipment of the product is expected to begin shortly."
"LCI posted net sales of $25.9 million for the third quarter of fiscal 2011, compared with $31.3 million for the third quarter of fiscal 2010. Gross profit was $5.3 million, down from the prior year period's $10.4 million."
To read the entire report visit: www.microstockprofit.com/lp/LCI
See what investors are saying about LCI at http://www.stockhideout.com
Get breaking news on LCI at http://thestockmarketwatch.com/
MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on MicroStockProfit please visit: http://www.microstockprofit.com
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.